Institut Paoli Calmettes Lymphoma Database
NCT02869542 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 16000
Last updated 2016-08-17
Summary
Database of Institut Paoli-Calmettes patients diagnosed with lymphoma
Conditions
Interventions
- OTHER
-
Data collection
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-12-31
Countries
- France
Study Locations
More Related Trials
-
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
NCT06024694 ·Status: ACTIVE_NOT_RECRUITING
-
The ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clinical and Laboratory Data From Patients With Lymphoid Malignancies. The Database Doesn't Require Biological Sample of Patients, it Records Only Information Based on the Patients' Medical File.
NCT03868527 ·Status: RECRUITING
-
Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans
NCT01287923 ·Status: COMPLETED
-
Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study
NCT05162170 ·Status: COMPLETED
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients
NCT04139252 ·Status: UNKNOWN
-
Low Grade Lymphoma
NCT01698866 ·Status: UNKNOWN ·Phase: PHASE4
-
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
NCT04824950 ·Status: RECRUITING ·Phase: NA
-
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
NCT05298293 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification of Occupational Exposures in Acute Hematologic Malignancy
NCT03316209 ·Status: COMPLETED
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
NCT02902874 ·Status: COMPLETED ·Phase: NA
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
NCT03265158 ·Status: UNKNOWN
-
SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers?
NCT03672682 ·Status: COMPLETED
-
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
NCT03571997 ·Status: UNKNOWN
-
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
NCT01660776 ·Status: COMPLETED
-
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)
NCT03859544 ·Status: UNKNOWN
-
Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
NCT05133505 ·Status: COMPLETED
-
Indolent Non Follicular Lymphomas Prognostic Project
NCT02904577 ·Status: COMPLETED
-
Bergamo Lymphoid Cancer Registry
NCT03131531 ·Status: RECRUITING
-
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
NCT00944567 ·Status: COMPLETED
-
Mediastinal Grey Zone Lymphoma From the LYSA
NCT03037177 ·Status: COMPLETED
-
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
NCT00144807 ·Status: COMPLETED ·Phase: PHASE2
-
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia
NCT02520895 ·Status: COMPLETED